Amlodipine in the treatment of Raynaud's phenomenon Br J Rheumatol. 2024 Jun;32 Raynaud Disease / drug therapy Treatment Outcome Substances Amlodipine
Calcium channel antagonists such as nifedipine, amlodipine and felodipine are frequently effective in the treatment of Raynaud s and are all fully funded in New Zealand. However, calcium channel blockers are less effective for treating patients with secondary Raynaud s, notably Raynaud s secondary to systemic sclerosis (sclerodoma). 9
Amlodipine is a calcium channel blocker and is a very common Raynaud's treatment. The most common side effects are probably swelling of the ankles and low BP.
Summary: The phase IV clinical study analyzes which people take Amlodipine and have Raynaud's phenomenon. It is created by eHealthMe based on reports of 346,875 people who have side effects when taking Amlodipine from the FDA, and is updated regularly.
Raynaud's may also develop as a side effect of some drugs such as beta Examples include nifedipine and amlodipine. These are in groups of drugs
12 medications found for 'raynauds phenomenon' amlodipine felodipine (plendil) isradipine (dynacirc) katerzia (amlodipine) nicardipine (cardene)
Amlodipine is a calcium channel blocker and is a very common Raynaud's treatment. The most common side effects are probably swelling of the ankles and low BP.
Calcium channel antagonists such as nifedipine, amlodipine and felodipine are frequently effective in the treatment of Raynaud's and are all fully funded in New
Amlodipine is a calcium channel blocker used in the treatment of Raynaud's syndrome. Read about secondary Raynaud's in rheumatoid arthritis.
Comments